Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aerobiotix is a private U.S. medical device company focused on air quality management solutions for healthcare environments, especially operating rooms. The company develops and manufactures ultraviolet- and filtration-based air purification and disinfection systems intended to reduce airborne microbial contamination and support surgical site infection risk reduction. Its core products include the Illuvia Sense surgical air disinfection system and other AeroCure and GermZone products that combine HEPA or ULPA filtration with proprietary Intraviolet technology. Aerobiotix markets its systems for hospitals and other institutional settings and emphasizes continuous operation in occupied rooms, environmental sensing, and real-time verification. The company appears to be a commercial-stage healthcare equipment manufacturer rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aerobiotix.